Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,876,919 papers from all fields of science
Search
Sign In
Create Free Account
CHOP regimen
Known as:
CTX/DOX/PRED/VCR
, ACOP
, CHOP
Expand
An abbreviation for a chemotherapy combination that is used to treat non-Hodgkin lymphoma and is being studied in the treatment of other types of…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
CDE protocol-cyclophosphamide/doxorubicin/etoposide
CHOP protocol-cyclophosphamide/doxorubicin/prednisone/vincristine
Cyclophosphamide
Doxorubicin
Expand
Broader (1)
cisplatin/cyclophosphamide/etoposide protocol
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma.
Anamarija M. Perry
,
T. Cardesa-Salzmann
,
+21 authors
D. Weisenburger
Blood
2012
Corpus ID: 13669878
Biologic factors that predict the survival of patients with a diffuse large B-cell lymphoma, such as cell of origin and stromal…
Expand
Highly Cited
2011
Highly Cited
2011
Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells.
Wendell S. Fortson
,
Shubhalaxmi Kayarthodi
,
+6 authors
E. Reddy
International Journal of Oncology
2011
Corpus ID: 23295596
An ETS family member, ETS Related Gene (ERG) is involved in the Ewing family of tumors as well as leukemias. Rearrangement of the…
Expand
Highly Cited
2009
Highly Cited
2009
Effects of the sesquiterpene lactone parthenolide on prostate tumor‐initiating cells: An integrated molecular profiling approach
B. Kawasaki
,
E. Hurt
,
+4 authors
W. Farrar
The Prostate
2009
Corpus ID: 13789407
Recent evidence suggests tumor‐initating cells (TICs), also called cancer stem cells, are responsible for tumor initiation and…
Expand
Highly Cited
2008
Highly Cited
2008
Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG‐positive prostate cancer
M. Björkman
,
K. Iljin
,
+4 authors
O. Kallioniemi
International Journal of Cancer
2008
Corpus ID: 37867732
Gene fusions between prostate‐specific, androgen responsive TMPRSS2 gene and oncogenic ETS factors, such as ERG, occur in up to…
Expand
Highly Cited
2007
Highly Cited
2007
Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA.
Su-Eun Han
,
Hyungu Kang
,
+4 authors
Y. Oh
International journal of pharmaceutics
2007
Corpus ID: 26562630
Highly Cited
2005
Highly Cited
2005
Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma.
S. Miles
,
Marie McGratten
Journal of Clinical Oncology
2005
Corpus ID: 35938976
Review
2003
Review
2003
A New Approach to the Diagnosis and Treatment of Intravascular Lymphoma
J. Baehring
,
J. Longtine
,
F. Hochberg
Journal of Neuro-Oncology
2003
Corpus ID: 11939429
In intravascular lymphoma (IVL) tumor cells are initially restricted to vascular lumina. Neurological syndromes predominate and…
Expand
Highly Cited
2003
Highly Cited
2003
Successful Treatment with Erwinia l -Asparaginase for Recurrent Natural Killer/T Cell Lymphoma
Yosuke Matsumoto
,
K. Nomura
,
+9 authors
M. Taniwaki
Leukemia and Lymphoma
2003
Corpus ID: 25256824
We describe a patient with natural killer (NK)/T cell lymphoma who relapsed after autologous peripheral blood stem cell…
Expand
Highly Cited
1991
Highly Cited
1991
Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma.
Susan E. O'Reilly
,
P. Klimo
,
Joseph M. Connors
Journal of Clinical Oncology
1991
Corpus ID: 42769534
Elderly patients with advanced-stage diffuse large-cell lymphomas (DLCLs) are either excluded from or under-represented in most…
Expand
Highly Cited
1986
Highly Cited
1986
Thyroid lymphomas stages IE and IIE: comparative results for radiotherapy only, combination chemotherapy only, and multimodality treatment.
A. Vigliotti
,
J. Kong
,
L. Fuller
,
W. Velasquez
International Journal of Radiation Oncology…
1986
Corpus ID: 46128235
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE